This trial is testing if an anti-rejection medication called Belatacept is safe for adult heart transplant patients.
1 Primary · 2 Secondary · Reporting Duration: 18 months
Experimental Treatment
12 Total Participants · 1 Treatment Group
Primary Treatment: Belatacept · No Placebo Group · Phase 2
Age 18 - 75 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: